Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma

BACKGROUND: Circulating tumor DNA (ctDNA) is a promising biomarker for non-invasive epidermal growth factor receptor mutations (EGFRm) detection in lung cancer patients, but existing methods have limitations in sensitivity and availability. In this study, we used the ΔCt value (mutant cycle threshol...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiang-Liang, Bai, Ri-Lan, Chen, Xiao, Zhao, Yu-Guang, Wang, Xu, Ma, Ke-Wei, Tian, Hui-Min, Han, Fu-Jun, Liu, Zi-Ling, Yang, Lei, Li, Wei, Gai, Fei, Cui, Jiu-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654465/
https://www.ncbi.nlm.nih.gov/pubmed/34669636
http://dx.doi.org/10.1097/CM9.0000000000001760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654465/
https://www.ncbi.nlm.nih.gov/pubmed/34669636
http://dx.doi.org/10.1097/CM9.0000000000001760

Ejemplares similares